“It is premature to jump to conclusions about the new virus variant identified in the U.K.,” said Dr. Wafaa El-Sadr, a professor of epidemiology at the Columbia University Mailman School of Public Health. “This will require careful scientific research to link the rise in (the) number of COVID-19 cases in the U.K. to the virus being more transmissible.”
Read the full article on City & State New York.
Read the latest ICAP updates on COVID-19 here
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu
